---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-23-087723"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2023-11-16T23:59:59+00:00"
generated_at: "2026-06-08T01:07:07.338539+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# NeuroOne receives Notice of Allowance for drug-delivery neural probe patent

## Summary
- USPTO issued Notice of Allowance for Patent App. 16/812,702 covering electrodes that deliver treatment agent to brain target.
- This is the third Notice of Allowance received by NeuroOne in recent months.
- Company expects patent issuance in the coming months.
- CEO says allowance strengthens IP portfolio and supports partnering for combination drug-delivery and sEEG recording.
- NeuroOne's portfolio now includes 3 allowed apps, 1 issued patent, 8 pending U.S. apps, and several foreign apps.

## SEC filing metadata
- accession: 0001213900-23-087723
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2023-11-16T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390023087723/0001213900-23-087723-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390023087723/ea188543-8k_neuroone.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-23-087723
- JSON: https://secwatch.observer/filing/0001213900-23-087723.json
- Plain text: https://secwatch.observer/filing/0001213900-23-087723.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.